Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

Nature Medicine

Volumn 10, Issue 5, 2004, Pages 510-517

  Merad, Miriam ^a,c   Hoffmann, Petra ^a,e   Ranheim, Erik ^a   Slaymaker, Sarah ^b   Manz, Markus G ^a,f   Lira, Sergio A ^c   Charo, Israel ^b   Cook, Donald N ^d   Weissman, Irving L ^a   Strober, Samuel ^a   Engleman, Edgar G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; LANGERHANS CELL; LIVER; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SPLEEN; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; CHEMOKINES; CHIMERA; DENDRITIC CELLS; GRAFT VS HOST DISEASE; LANGERHANS CELLS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, CHEMOKINE; SKIN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS; ULTRAVIOLET THERAPY;

ANIMALIA;

EID: 2442658900     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1038     Document Type: Article

References (37)

1. Teshima, T. & Ferrara, J.L. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin. Hematol. 39, 15-22 (2002).
2. Goker, H., Haznedaroglu, I.C. & Chao, N.J. Exp. Hematol. 29, 259-277 (2001).
3. Ferrara, J.L., Levy, R. & Chao, N.J. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol. Blood Marrow Transplant. 5, 347-356 (1999).
4. Ho, V.T. & Soiffer, R.J. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98, 3192-3204 (2001).
5. Shlomchik, W.D. et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285. 412-415 (1999).
6. + T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109, 1335-1344 (2002).
7. Katz, S.I. & Breathnach, S.M. Immunopathology of cutaneous graft-versus-host disease. Am. J. Dermatopathol. 9, 343-348 (1987).
8. Stingl, G., Tamaki, K. & Katz, S.I. Origin and function of epidermal Langerhans cells. Immunol. Rev. 53, 149-174 (1980).
9. Schuler, G. & Steinman, R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546 (1985).
10. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
11. Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135-1141 (2002).
12. + T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189, 1073-10131 (1999).
13. Caux, C. et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22, 345-369 (2000).
14. Homey, B. et al. Up-regulation of macrophage inflammatory protein-3 α/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621-6632 (2000).
15. Katz, S.I., Tamaki, K. & Sachs, D.H. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282, 324-325 (1979).
16. Frelinger, J.G., Hood, L., Hill, S. & Frelinger, J.A. Mouse epidermal la molecules have a bone marrow origin. Nature 282, 321-323 (1979).
17. Emile, J.F. et al. Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation. Br. J. Haematol. 98, 480-484 (1997).
18. Cook, D.N. et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12, 495-503 (2000).
19. Okada, T. et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196, 65-75 (2002).
20. Pugh, C.W., MacPherson, G.G. & Steer, H.W. Characterization of nonlymphoid cells derived from rat peripheral lymph. J. Exp. Med. 157, 1758-1779 (1983).
21. Huang, F.P. et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435-444 (2000).
22. Liu, K. et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097 (2002).
23. Scheinecker, C., McHugh, R., Shevach, E.M. & Germain, R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090 (2002).
24. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099-1104 (2002).
25. Drexhage, H.A., Mullink, H., de Groot, J., Clarke, J. & Balfour, B.M. A study of cells present in peripheral lymph of pigs with special reference to a type of cell resembling the Langerhans cell. Cell Tissue Res. 202, 407-430 (1979).
26. Kelly, R.H., Balfour, B.M., Armstrong, J.A. & Griffiths, S. Functional anatomy of lymph nodes. II. Peripheral lymph-borne mononuclear cells. Anat. Rec. 190, 5-21 (1978).
27. Hemmi, H. et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int. Immunol. 13, 695-704 (2001).
28. + T cells to elicit hepatic graft-versus-host disease. J. Immunol. 169, 7111-7118 (2002).
29. Teshima, T. et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 6, 575-581 (2002).
30. Vogelsang, G.B. How I treat chronic graft-versus-host disease. Blood 97, 1196-1201 (2001).
31. Perreault, C. et al. Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease. Br. J. Haematol. 60, 253-260 (1985).
32. Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (1994).
33. Kagi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37 (1994).
34. Boring, L. et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552-2561 (1997).
35. Kondo, M., Weissman, I.L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672 (1997).
36. Zeng, D., Dejbakhsh-Jones, S. & Strober, S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood 90, 453-463 (1997).
37. Cvetovic-Cvrlje, M., Roers, B.A., Waurzyniak, B., Liu, X. & Uckun, F. Targeting janus kinase 3 to attenuate the severity of acute graft versus host disease across the major histocompatibility barrier in mice. Blood 98, 1607-1613 (2001).